Natus Medical (BABY) Soars on Financial Results, S2C Global Systems

S2C Global Systems Inc. (STWG)

STWG increased its activity on Thursday's trading session, jumping +7.69% to $0.014, with 1,201,700 shares traded during the day

STWG is in the business of extracting both base and precious metals from known resource deposits primarily in the ore rich regions of Mexico.

Mexico is rich in natural resources. Gold mines are scattered throughout its southern regions, and silver, copper, iron, lead, and zinc ores can be found virtually anywhere within its interior.

Iron ore is a major component in many modern office towers, including iconic structures around the world. It is also used extensively in motor vehicles, washing machines, refrigerators, ovens and other whitegoods.

This month, Morgan Stanley raised its Iron ore forecast for the first and second quarters of year 2014. According to analysts Peter Richardson and Joel Crane, iron ore will average $130 a ton in the first three months, $5 more than previously forecast, and $120 in the second quarter, up from $117.

STWG is able to provide the technical expertise, knowledge of the local business environment and funding required for bringing existing undercapitalized small-scale mining operations into full production utilizing economies of scale to provide maximum return to itsr shareholders.

More about S2C Global Systems Inc. (STWG) at www.s2cglobalresources.com

**

Natus Medical Inc. (Nasdaq:BABY)

Shares of BABY skyrocketed after the company reported record third quarter 2013 financial results, exceeded its revenue and earnings guidance and improved its non-GAAP gross profit margin to 61%

For the third quarter ended September 30, 2013, BABY posted revenue of $85.4 million, up 5% from $81.0 million in the same period the prior year, and net income of$6.3 million, or $0.20 per diluted share, compared with a net loss of $1.7 million, or $0.06 per share, in the third quarter of 2012. In a non-GAAP basis, BABY reported earnings per share of $0.30 per diluted share during the period, representing an 88% increase year over year.

BABY has raised its fourth quarter and full year 2013 revenue and earnings guidance. According to its business outlook, BABY expects revenue of $87 million to $90 million and non-GAAP earnings per share of $0.30 to $0.32, compared to prior revenue guidance for the fourth quarter 2013 of $84 million to $88 million and non-GAAP earnings per share of $0.22 to $0.25.

For the full year 2013 BABY now expects revenue of $340 million to $343 million and non-GAAP earnings per share of $0.95 to $0.97. This compares to prior revenue guidance for the full year 2013 of $332 million to $338 million and non-GAAP earnings per share of $0.76 to $0.82.

BABY stock last trade was at $19.31, up $4.20 or 27.80%, with a volume of 2,143,397 shares

BABY is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.

More about Natus Medical Inc. (Nasdaq:BABY) at www.natus.com .

********************************

Read Full Disclaimer at www.pennyomega.com/disclaimer